{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:54:28Z","timestamp":1791356068081,"version":"4.3.1"},"reference-count":18,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1002\/jps.22329","type":"journal-article","created":{"date-parts":[[2010,9,13]],"date-time":"2010-09-13T20:52:22Z","timestamp":1284411142000},"page":"896-903","source":"Crossref","is-referenced-by-count":59,"title":["Percutaneous Permeation of Betamethasone 17-Valerate Incorporated in Lipid Nanoparticles"],"prefix":"10.1016","volume":"100","author":[{"given":"Jin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1002\/jps.22329_bb0005","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.addr.2007.04.006","article-title":"Lipid nanoparticles for improved topical application of drugs for skin diseases","volume":"59","author":"Schafer-Korting","year":"2007","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1002\/jps.22329_bb0010","series-title":"Pharmacotherapy: A pathophysiologic approach","first-page":"xxxii","author":"DiPiro","year":"2008"},{"issue":"1 Suppl. 1","key":"10.1002\/jps.22329_bb0015","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1016\/j.jaad.2005.04.030","article-title":"Corticosteroids: Options in the era of steroid-sparing therapy","volume":"53","author":"Del Rosso","year":"2005","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl. 1","key":"10.1002\/jps.22329_bb0020","doi-asserted-by":"crossref","first-page":"S131","DOI":"10.1016\/S0169-409X(02)00118-7","article-title":"Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations","volume":"54","author":"Muller","year":"2002","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"10.1002\/jps.22329_bb0025","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0939-6411(00)00087-4","article-title":"Solid lipid nanoparticles (SLN) for controlled drug delivery\u2014a review of the state of the art","volume":"50","author":"Muller","year":"2000","journal-title":"Eur J Pharm Biopharm"},{"issue":"2","key":"10.1002\/jps.22329_bb0030","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ejpb.2008.08.019","article-title":"Nanoparticles for skin penetration enhancement\u2014a comparison of a dendritic core-multishell-nanotransporter and solid lipid nanoparticles","volume":"71","author":"Kuchler","year":"2009","journal-title":"Eur J Pharm Biopharm"},{"issue":"3","key":"10.1002\/jps.22329_bb0035","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0738-081X(02)00368-1","article-title":"The use of corticosteroids and corticosteroid phobia in atopic dermatitis","volume":"21","author":"Charman","year":"2003","journal-title":"Clin Dermatol"},{"issue":"5","key":"10.1002\/jps.22329_bb0040","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1002\/jps.21549","article-title":"Experimental design for the optimization of lipid nanoparticles","volume":"98","author":"Zhang","year":"2009","journal-title":"J Pharm Sci"},{"issue":"2","key":"10.1002\/jps.22329_bb0045","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0939-6411(03)00067-5","article-title":"Solid lipid nanoparticle and microemulsion for topical delivery of triptolide","volume":"56","author":"Mei","year":"2003","journal-title":"Eur J Pharm Biopharm"},{"issue":"1","key":"10.1002\/jps.22329_bb0050","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ijpharm.2004.02.032","article-title":"Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery","volume":"278","author":"Souto","year":"2004","journal-title":"Int J Pharm"},{"issue":"1\u20132","key":"10.1002\/jps.22329_bb0055","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ijpharm.2003.12.016","article-title":"Preparation and characterization of solid lipid nanoparticles containing peptide","volume":"273","author":"Hu","year":"2004","journal-title":"Int J Pharm"},{"issue":"2","key":"10.1002\/jps.22329_bb0060","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0939-6411(97)00150-1","article-title":"Solid lipid nanoparticles (SLN) for controlled drug delivery\u2014drug release and release mechanism","volume":"45","author":"zur Muhlen","year":"1998","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1002\/jps.22329_bb0065","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1001\/archderm.1963.01590240026005","article-title":"Preparation of isolated sheets of human stratum corneum","volume":"88","author":"Kligman","year":"1963","journal-title":"Arch Dermatol"},{"issue":"2","key":"10.1002\/jps.22329_bb0070","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0378-5173(97)00358-X","article-title":"Release of rooperol tetraacetate from topical bases: In vitro studies using silicone membrane","volume":"161","author":"Pefile","year":"1998","journal-title":"Int Pharm"},{"issue":"2","key":"10.1002\/jps.22329_bb0075","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0378-5173(99)00426-3","article-title":"Comparison of wax and glyceride solid lipid nanoparticles (SLN)","volume":"196","author":"Jenning","year":"2000","journal-title":"Int J Pharm"},{"issue":"11","key":"10.1002\/jps.22329_bb0080","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1002\/jps.2600821118","article-title":"Skin permeation enhancement of tegafur by ethanol\/panasate 800 or ethanol\/water binary vehicle and combined effect of fatty acids and fatty alcohols","volume":"82","author":"Lee","year":"1993","journal-title":"J Pharm Sci"},{"issue":"1","key":"10.1002\/jps.22329_bb0085","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jconrel.2004.06.015","article-title":"Skin penetration and distribution of polymeric nanoparticles","volume":"99","author":"Alvarez-Roman","year":"2004","journal-title":"J Control Release"},{"issue":"3","key":"10.1002\/jps.22329_bb0090","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0168-3659(04)00167-1","article-title":"Transdermal delivery of mixnoxidil with block copolymer nanoparticles","volume":"97","author":"Shim","year":"2004","journal-title":"J Control Release"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354915322437?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354915322437?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T17:43:01Z","timestamp":1559670181000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354915322437"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S0022354915322437"],"URL":"https:\/\/doi.org\/10.1002\/jps.22329","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]}}}